T1	Participants 0 150	A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori.
T2	Participants 186 210	Helicobacter pylori (HP)
T3	Participants 316 467	to evaluate a novel four-drug regimen (three antibiotics and a proton pump inhibitor (PPI)) for eradication of HP infection in treatment-naive patients
T4	Participants 559 637	endoscopy and stool antigen testing were eligible for inclusion in this study.
T5	Participants 681 688	6 weeks
T6	Participants 509 542	gastritis or peptic ulcer disease
T7	Participants 1255 1353	HP eradication was confirmed by stool antigen testing at least 4 weeks after cessation of therapy.
T8	Participants 1696 1832	This open-label, prospective trial demonstrates that LOAD is a highly active regimen for the treatment of HP in treatment-naive patients
T9	Participants 1864 1931	trial is warranted to further evaluate the efficacy of this regimen
